The pleiotropic benefits of statins include the ability to reduce CD47 and amplify the effect of pro-efferocytic therapies in atherosclerosis
Kai-Uwe Jarr, Jianqin Ye, Yoko Kojima, Zhongde Ye, Hua Gao, Sofie Schmid, Lingfeng Luo, Richard A. Baylis, Mozhgan Lotfi, Nicolás López, Anne V. Eberhard, Bryan Ronain Smith, Irving L. Weissman, Lars Mäegdefessel, Nicholas J. Leeper
Topics & Concepts
CD47MedicineImmunologyPhagocytosisPhagocytosis and Immune RegulationAtherosclerosis and Cardiovascular DiseasesCell death mechanisms and regulation